全文获取类型
收费全文 | 2264篇 |
免费 | 236篇 |
国内免费 | 71篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 44篇 |
妇产科学 | 32篇 |
基础医学 | 255篇 |
口腔科学 | 40篇 |
临床医学 | 275篇 |
内科学 | 408篇 |
皮肤病学 | 32篇 |
神经病学 | 73篇 |
特种医学 | 185篇 |
外科学 | 231篇 |
综合类 | 280篇 |
现状与发展 | 1篇 |
一般理论 | 3篇 |
预防医学 | 195篇 |
眼科学 | 27篇 |
药学 | 140篇 |
中国医学 | 53篇 |
肿瘤学 | 287篇 |
出版年
2023年 | 19篇 |
2022年 | 39篇 |
2021年 | 71篇 |
2020年 | 48篇 |
2019年 | 59篇 |
2018年 | 66篇 |
2017年 | 47篇 |
2016年 | 55篇 |
2015年 | 50篇 |
2014年 | 75篇 |
2013年 | 92篇 |
2012年 | 107篇 |
2011年 | 121篇 |
2010年 | 81篇 |
2009年 | 71篇 |
2008年 | 86篇 |
2007年 | 94篇 |
2006年 | 117篇 |
2005年 | 92篇 |
2004年 | 148篇 |
2003年 | 186篇 |
2002年 | 164篇 |
2001年 | 127篇 |
2000年 | 77篇 |
1999年 | 50篇 |
1998年 | 54篇 |
1997年 | 41篇 |
1996年 | 28篇 |
1995年 | 27篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 17篇 |
1991年 | 18篇 |
1990年 | 13篇 |
1989年 | 25篇 |
1988年 | 13篇 |
1987年 | 10篇 |
1986年 | 14篇 |
1985年 | 10篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 10篇 |
1981年 | 5篇 |
1980年 | 7篇 |
1978年 | 10篇 |
1977年 | 6篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1973年 | 7篇 |
1968年 | 4篇 |
排序方式: 共有2571条查询结果,搜索用时 31 毫秒
71.
Dimicoli S Bensoussan D Latger-Cannard V Straczek J Antunes L Mainard L Dao A Barbe F Araujo C Clément L Feugier P Lecompte T Stoltz JF Bordigoni P 《Bone marrow transplantation》2003,32(7):733-737
We describe two brothers who suffered from hyper-IgM syndrome (HIGM1) with similar clinical features: recurrent infections, especially cryptosporidium gastroenteritis with cholangitis. Their activated T cells did not express CD40L. Nucleotide sequencing revealed a mutation in both boys with respect to intron 4 and exon 5 boundaries of the CD40L gene in Xq26. They underwent successful bone marrow transplantation (BMT) from HLA-geno-identical siblings. The Cryptosporidium infection and cholangitis resolved thereafter. At 6 months after BMT, expression of CD40L on activated T lymphocytes was normal. After 1 year, both boys are well, and immune reconstitution has improved. Based on these two successful experiences, BMT with a genoidentical sibling seems a reasonable therapeutic approach for HIGM1, if Cryptosporidium infection occurs. 相似文献
72.
73.
Bin Zhang Ke Yi Li Hai Ying Chen Shao Dong Pan Shuang Feng Chen Wei Feng Zhang Chun Peng Xia Li Cheng Jiang Xian Bin Liu Feng Jun Zhao Dao Ying Yuan Le Xin Wang Ya Ping Wu Shu Wei Liu 《International journal of medical sciences》2013,10(10):1301-1306
Background: The Nemo-like kinase (NLK) is a serine/threonine-protein kinase that involved in a number of signaling pathways regulating cell fate. Variation of NLK has been shown to be associated with the risk of cancer. However, the function of NLK in oral adenosquamous carcinoma cells line CAL-27 is unknown.Methods: In this study, we evaluated the function of NLK in CAL-27 cells by using lentivirus-mediated RNA silence. The targeted gene expression, cell proliferation and cell cycle are investigated by RT-PCR, western-blot, MTT method, colony forming assay and flow cytometry analysis respectively.Results: After NLK silencing, the number of colonies was significantly reduced (54±5 colonies/well compared with 262±18 colonies/well in non-infected or 226±4 colonies/well in negative control group (sequence not related to NLK sequence with mismatched bases). Using crystal violet staining, we also found that the cell number per colony was dramatically reduced. The RNA silencing of NLK blocks the G0/G1 phase to S phase progression during the cell cycle.Conclusions: These results suggest that NLK silencing by lentivirus-mediated RNA interference would be a potential therapeutic method to control oral squamous carcinoma growth. 相似文献
74.
Thanh Q. Bui Huynh Thi Phuong Loan Tran Thi Ai My Duong Tuan Quang Bui Thi Phuong Thuy Vo Duy Nhan Phan Tu Quy Pham Van Tat Duy Quang Dao Nguyen Tien Trung Lam K. Huynh Nguyen Thi Ai Nhung 《RSC advances》2020,10(51):30961
Ribavirin and remdesivir have been preclinically reported as potential drugs for the treatment of SARS-CoV-2 infection, while light silver tetrylene complexes (NHEPh–AgCl and (NHEPh–AgCl)2 with E = C, Si, and Ge) have gained significant interest due to their promising applicability on the cytological scale. Firstly, the structures and bonding states of silver–tetrylene complexes (NHE–Ag) and bis-silver–tetrylene complexes (NHE–Ag-bis) were investigated using density functional theory (DFT) at the BP86 level with the def2-SVP and def2-TZVPP basis sets. Secondly, the inhibitory capabilities of the carbene complexes (NHC–Ag and NHC–Ag-bis) and the two potential drugs (ribavirin and remdesivir) on human-protein ACE2 and SARS-CoV-2 protease PDB6LU7 were evaluated using molecular docking simulation. The carbene ligand NHC bonds in a head-on configuration with AgCl and (AgCl)2, whereas, the other NHE (E = Si and Ge) tetrylene ligands bond in a side-on mode to the metal fragments. The bond dissociation energy (BDE) of the NHE–Ag bond in the complex families follows the order of NHC–Ag > NHSi–Ag > NHGe–Ag and NHSi–Ag-bis > NHGe–Ag-bis > NHC–Ag-bis. The natural bond orbital analysis implies that the [NHEPh→AgCl] and [(NHEPh)2→(AgCl)2] donations are derived mainly from the σ- and π-contributions of the ligands. The docking results indicate that both the ACE2 and PDB6LU7 proteins are strongly inhibited by silver–carbene NHC–Ag, bis-silver–carbene NHC–Ag-bis, ribavirin, and remdesivir with the docking score energy values varying from −17.5 to −16.5 kcal mol−1 and −16.9 to −16.6 kcal mol−1, respectively. The root-mean-square deviation values were recorded to be less than 2 Å in all the calculated systems. Thus, the present study suggests that silver–carbene NHC–Ag and bis-silver–carbene NHC–Ag-bis complexes are potential candidates to inhibit ACE2 and PDB6LU7, and thus potentially conducive to prevent infection caused by the SARS-CoV-2 virus.Simultaneous inhibition of silver–carbene complexes to ACE2 and PDB6LU7 is conducive for the prevention of SARS-CoV-2 infection: a virtual prediction. 相似文献
75.
Protein C is a vitamin K-dependent plasma serine protease zymogen, which upon activation, functions as an anticoagulant. Protein C activation is catalyzed by a complex of thrombin (T) with thrombomodulin (TM). This activation is Ca(2+)-dependent, but Ca2+ inhibits protein C activation by thrombin alone. In most proteases, specificity is determined primarily by the residues that lie near the scissile bond. In protein C, the P2 position is Pro, whereas in the fibrinogen A chain, P2 is Val. We have expressed a Pro-->Val mutant of protein C (P168V) in mammalian cells. At saturating Ca2+, the P168V and wild-type proteins were activated by the T-TM complex equivalently, but half maximal rates of activation were obtained at 50 mumol/L Ca2+ for wild type and approximately 5 mmol/L Ca2+ for the P168V mutant. In the absence of TM, Ca2+ no longer inhibited the activation of the P168V mutant. These results indicate that Pro168 influences the Ca(2+)- dependent conformational changes in protein C that control activation. Recently, a patient with thrombotic complications has been identified with a Pro168-->Leu substitution. Both the P168V and the P168L mutation lead to impaired secretion caused by retention within the cell. 相似文献
76.
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies 总被引:1,自引:0,他引:1
Second or third chemotherapy-induced remissions in acute myelogenous leukemia (AML) are limited by early relapse of the leukemia. We developed monoclonal antibodies (MoAbs) that are cytotoxic to myeloid leukemia cells to treat bone marrow from these patients ex vivo for autologous transplantation. In this pilot study, bone marrow was harvested from ten patients with AML in remission, treated with one or two complement-fixing MoAbs, PM-81 and AML-2-23, which react with myeloid differentiation antigens, incubated with rabbit complement, and cryopreserved. These MoAbs were chosen because they have broad reactivity with AML cells but not with pluripotent progenitor cells. At the time of transplant, 6 patients were in second complete remission, 1 each was in third complete or partial remission, and 2 were in early first relapse. The patients were treated with cyclophosphamide (60 mg/kg a day for 2 days) and total body irradiation (200 cGy twice a day for 3 days) and given infusions of MoAb-treated bone marrow. Full bone marrow reconstitution was observed in eight patients; two patients did not recover platelets. Seven of the ten patients are surviving and disease-free at 21.0, 15.0, 13.0, 10.0, 6.0, 3.0, and 2.0 months posttransplant. Treating bone marrow with MoAbs to myeloid differentiation antigens does not interfere with pluripotential stem cell engraftment. Longer follow-up and a controlled study are necessary to prove that the apparent efficacy of this therapeutic approach in some patients is attributable to MoAb-mediated killing of leukemia cells. 相似文献
77.
78.
79.
80.